{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:46:49Z","timestamp":1780609609386,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2011.12.133","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T07:11:27Z","timestamp":1326179487000},"page":"2600-2604","source":"Crossref","is-referenced-by-count":36,"title":["Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"K.","family":"Leder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.133_bib0005","unstructured":"WHO International Travel and Health: the Green book; 2012."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0010","unstructured":"CDC Health Information for International travel: the Yellow book; 2012."},{"issue":"November (5)","key":"10.1016\/j.vaccine.2011.12.133_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jinf.2009.08.018","article-title":"Hepatitis B immunization coverage and risk behaviour among Danish travellers: are immunization strategies based on single journey itineraries rational?","volume":"59","author":"Nielsen","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2011.12.133_bib0020","unstructured":"US Department of Commerce ITA Tourism Industries. Profile of U.S. Resident Travelers Visiting Overseas Destinations: 2009 outbound. Reported From: Survey of International Air Travelers. US Department of Commerce ITA Tourism Industries. Accessed June 2011 [cited; available from: http:\/\/tinet.ita.doc.gov\/outreachpages\/download_data_table\/2009_Outbound_Profile.pdfhttp:\/\/tinet.ita.doc.gov\/]."},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/0003-4819-142-1-200501040-00013","article-title":"Health disparities among travelers visiting friends and relatives abroad","volume":"142","author":"Angell","year":"2005","journal-title":"Ann Intern Med"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.12.133_bib0030","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1001\/jama.291.23.2856","article-title":"Travel medicine considerations for North American immigrants visiting friends and relatives","volume":"291","author":"Bacaner","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.12.133_bib0035","first-page":"1185","article-title":"Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network","volume":"43","author":"Leder","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.12.133_bib0040","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","article-title":"The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis","volume":"35","author":"Fisman","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.12.133_bib0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tmaid.2005.10.002","article-title":"Hepatitis A vaccines and the elderly","volume":"4","author":"Genton","year":"2006","journal-title":"Travel Med Infect Dis"},{"issue":"May (25)","key":"10.1016\/j.vaccine.2011.12.133_bib0050","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1708-8305.2007.00164.x","article-title":"Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study","volume":"15","author":"Gautret","year":"2008","journal-title":"J Travel Med"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1708-8305.2008.00256.x","article-title":"Rabies postexposure management of travelers presenting to travel health clinics in Auckland and Hamilton, New Zealand","volume":"16","author":"Shaw","year":"2009","journal-title":"J Travel Med"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2011.12.133_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1708-8305.2008.00283.x","article-title":"Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention","volume":"16","author":"Altmann","year":"2009","journal-title":"J Travel Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.12.133_bib0070","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4269\/ajtmh.2010.09-0699","article-title":"Rabies exposure risk among foreign backpackers in Southeast Asia","volume":"82","author":"Piyaphanee","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2011.12.133_bib0075","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.vaccine.2006.12.034","article-title":"Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network","volume":"25","author":"Gautret","year":"2007","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.12.133_bib0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(91)90221-Q","article-title":"Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?","volume":"9","author":"Bernard","year":"1991","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/649873","article-title":"Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/649211","article-title":"Postexposure rabies prophylaxis completed in 1 week: preliminary study","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"September (9389)","key":"10.1016\/j.vaccine.2011.12.133_bib0095","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"Hepatitis A booster vaccination: is there a need?","volume":"362","author":"Van Damme","year":"2003","journal-title":"Lancet"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.12.133_bib0100","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/606119","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose","volume":"200","author":"McMahon","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.133_bib0105","unstructured":"Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II. Immunization of adults. MMWR Recomm Rep 2006;55(December (RR-16)):1\u201333; quiz CE1-4."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0110","unstructured":"CDC Travelers\u2019 Health Yellow Book, Chapter 3: hepatitis B [cited; available from: http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2012\/chapter-3-infectious-diseases-related-to-travel\/hepatitis-b.htm]."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0115","unstructured":"World Health Organisation (Green Book): International travel and health. Chapter 6: vaccine-preventable diseases and vaccines; 2011 [cited; available from: http:\/\/www.who.int\/ith\/chapters\/ith2011chap6.pdf]."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0120","unstructured":"Chen LH BE, Wilson ME, MacLeod WB, Yanni E, Karchmer AW, Ooi WW, et al. Hepatitis B status in travellers seen in the Boston Area Travel Medicine Network (BATMN). In: Abstracts for the 7th European congress on tropical medicine and international health; 2011."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0125","unstructured":"CDC Travelers\u2019 Health Yellow Book, Chapter 3: Yellow fever [cited; available from: http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2012\/chapter-3-infectious-diseases-related-to-travel\/yellow-fever.htm]."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0130","unstructured":"Rossi I, Genton, B. The reliability of pre-travel history to decide on appropriate counselling and vaccinations: a prospective study. In: Abstracts from the 12th conference of the international society of travel medicine, FC02.04."},{"issue":"April (14)","key":"10.1016\/j.vaccine.2011.12.133_bib0135","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.12.133_bib0140","unstructured":"CDC Travelers\u2019 Health Yellow Book, Chapter 3: Japanese encephalitis [cited; available from: http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2012\/chapter-3-infectious-diseases-related-to-travel\/japanese-encephalitis.htm]."},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.133_bib0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QCO.0b013e32833c1d01","article-title":"Japanese encephalitis: update on vaccines and vaccine recommendations","volume":"23","author":"Wilder-Smith","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.133_bib0150","unstructured":"Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine \u2013 advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2011;60(May (20)):661\u20133."},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.12.133_bib0155","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4161\/hv.6.12.13057","article-title":"Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults","volume":"6","author":"Nasveld","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2011.12.133_bib0160","unstructured":"Updated recommendations for use of meningococcal conjugate vaccines \u2013 Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;60(January (3)):72\u20136."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0165","unstructured":"Typhoid Immunization Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(December (14)):1\u20137."},{"key":"10.1016\/j.vaccine.2011.12.133_bib0170","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/499816","article-title":"A virus infections in travelers, 1988\u20132004","volume":"42","author":"Mutsch","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1708-8305.2008.00268.x","article-title":"Risk of hepatitis B for travelers: is vaccination for all travelers really necessary?","volume":"16","author":"Sonder","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2011.12.133_bib0180","doi-asserted-by":"crossref","unstructured":"Steffen R. Risks of hepatitis B for travellers. Vaccine 1990;(March (8 Suppl)):S31\u20132; discussion S41\u20133.","DOI":"10.1016\/0264-410X(90)90213-6"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2011.12.133_bib0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1708-8305.2009.00334.x","article-title":"Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland","volume":"16","author":"Hatz","year":"2009","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.133_bib0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.12.133_bib0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1708-8305.1994.tb00548.x","article-title":"Meningococcal disease in travelers: vaccination recommendations","volume":"1","author":"Koch","year":"1994","journal-title":"J Travel Med"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2011.12.133_bib0200","first-page":"127","article-title":"Risk of possible exposure to rabies among tourists and foreign residents in Nepal","volume":"9","author":"Pandey","year":"2002","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.133_bib0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vaccine.2011.11.007","article-title":"Rabies vaccination for international travelers","volume":"30","author":"Gautret","year":"2012","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.12.133_bib0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.2009.1229","article-title":"Typhoid fever in the United States, 1999\u20132006","volume":"302","author":"Lynch","year":"2009","journal-title":"J Am Med Assoc"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2011.12.133_bib0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1708-8305.2008.00216.x","article-title":"Imported typhoid fever in Switzerland, 1993 to 2004","volume":"15","author":"Keller","year":"2008","journal-title":"J Travel Med"},{"issue":"10","key":"10.1016\/j.vaccine.2011.12.133_bib0220","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T08:27:13Z","timestamp":1561192033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":44,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X11020949"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.133","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}